Physician profile

Jeffrey Zoltan

Erie, PA

NPI 1821651217

$1,410.22

in general payments reported to CMS, 2019-2025

7 companies · $977 in 2025

The $977 reported for 2025 was more than what 88% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$723.46
Food and Beverage$671.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $771.46 2025
Innovation Technologies INC $243.64 2022-2025 Irrisept
Stryker Corporation $145.22 2024 T2 Alpha
Convatec INC. $101.15 2023
Mid-Atlantic Surgical Systems, LLC $82.34 2023-2025
Medical Device Business Services, INC. $52.74 2025 Na
Pinnacle, INC $13.67 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey Zoltan

$1,410.22

in general payments reported 2019-2025

Years
2022-2025
Top company
Arthrex, INC.
Context
The $977 reported for 2025 was more than what 88% of providers received nationally.

https://glasscript.com/doctor/11433892/jeffrey-zoltan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.